AG-636

Research use only, not for human use.

AG-636 is a potent, reversible, selective and orally active DHODH inhibitor(IC50 of 17 nM). It has strong anticancer effects.

AG-636 is a potent, reversible, selective and orally active DHODH inhibitor(IC50 of 17 nM). It has strong anticancer effects.

——

Animal Model:Transgenic female 6-8-week-old CB17/Icr-Prkdcscid/IcrIcoCrl (CB17 SCID) mice injected with OCILY19 cells Dosage:10 mg/kg, 30 mg/kg, or 100 mg/kg Administration:Oral gavage; twice daily; for 14 days Result:Resulted in robust tumor growth inhibition in xenograft lymphoma tumor models.

——

Metabolic Enzyme/Protease

Dehydrogenase

DHODH|DNA/RNA Synthesis

——

——

1623416-31-8

343.38

C21H17N3O2

>98% (HPLC)

DMSO:31.25 mg/mL (91.01 mM; Need ultrasonic)

O=C(C1=C(N(C)N=N2)C2=CC(C3=CC=C(C4=CC=CC=C4C)C=C3)=C1)O

——

(-20℃)

With Ice Pack

≥ 2 years